Search hospitals > California > Fremont
Washington Hospital
Claim this profileFremont, California 94538
Global Leader in Breast Cancer
Conducts research for Parotid Gland Cancer
Conducts research for Breast cancer
Conducts research for Lung Cancer
Conducts research for Stenosis
33 reported clinical trials
2 medical researchers
Summary
Washington Hospital is a medical facility located in Fremont, California. This center is recognized for care of Breast Cancer, Parotid Gland Cancer, Breast cancer, Lung Cancer, Stenosis and other specialties. Washington Hospital is involved with conducting 33 clinical trials across 54 conditions. There are 2 research doctors associated with this hospital, such as Bogdan S. Eftimie and Jes Alexander.Area of expertise
1Breast Cancer
Global LeaderHER2 positive
ER positive
ER negative
2Parotid Gland Cancer
Stage IV
HER2 positive
ER positive
Top PIs
Bogdan S. EftimieWashington Hospital4 years of reported clinical research
Studies Breast Cancer
Studies Parotid Gland Cancer
12 reported clinical trials
37 drugs studied
Jes AlexanderWashington Hospital4 years of reported clinical research
Studies Prostate Adenocarcinoma
Studies Prostate Cancer
2 reported clinical trials
14 drugs studied
Clinical Trials running at Washington Hospital
Breast Cancer
Lung Cancer
Rectal Cancer
Non-Small Cell Lung Cancer
Breast cancer
Prostate Adenocarcinoma
Parotid Gland Cancer
Prostate Cancer
Colon Cancer
Cervical Adenocarcinoma
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Washington Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.